Global Herbal Supplements Market

1 INTRODUCTION OF GLOBAL HERBAL SUPPLEMENTS MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL HERBAL SUPPLEMENTS MARKET OUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework

5 GLOBAL HERBAL SUPPLEMENTS MARKET, BY SOURCE
5.1 Overview
5.2 Roots
5.3 Fruits and Vegetables
5.4 Barks
5.5 Leaves
5.6 Others

6 GLOBAL HERBAL SUPPLEMENTS MARKET, BY APPLICATION
6.1 Overview
6.2 Food and Beverages
6.3 Pharmaceuticals
6.4 Personal Care
6.5 Others

7 GLOBAL HERBAL SUPPLEMENTS MARKET, BY FORM
7.1 Overview
7.2 Oils
7.3 Syrups
7.4 Powders
7.5 Tablets and Capsules
7.6 Others

8 GLOBAL HERBAL SUPPLEMENTS MARKET, BY FUNCTION
8.1 Overview
8.2 Aroma
8.3 Medicinal
8.4 Others

9 GLOBAL HERBAL SUPPLEMENTS MARKET, BY GEOGRAPHY
9.1 Overview
9.2 North America Regional Market Estimates and Forecasts, 2012 - 2025
9.2.1 U.S.
9.2.2 Canada
9.2.3 Mexico
9.3 Europe Regional Market Estimates and Forecasts, 2012 - 2025
9.3.1 Germany
9.3.2 U.K.
9.3.3 France
9.3.4 Rest of Europe
9.4 Asia Pacific Regional Market Estimates and Forecasts, 2012 - 2025
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Rest of Asia Pacific
9.5 Latin America Regional Market Estimates and Forecasts, 2012 - 2025
9.5.1 Brazil
9.5.2 Argentina
9.6 Rest of the World Regional Market Estimates and Forecasts, 2012 - 2025

10 GLOBAL HERBAL SUPPLEMENTS MARKET COMPETITIVE LANDSCAPE
10.1 Overview
10.2 Company Market Share
10.3 Vendor Landscape
10.4 Key Development Strategies

11 COMPANY PROFILES
11.1 Herbalife
11.1.1 Overview
11.1.2 Financial Performance
11.1.3 Product Outlook
11.1.4 Key Developments

11.2 Glanbia PLC
11.2.1 Overview
11.2.2 Financial Performance
11.2.3 Product Outlook
11.2.4 Key Developments

11.3 Archer Daniels Midland Company
11.3.1 Overview
11.3.2 Financial Performance
11.3.3 Product Outlook
11.3.4 Key Developments

11.4 Ricola AG
11.4.1 Overview
11.4.2 Financial Performance
11.4.3 Product Outlook
11.4.4 Key Developments

11.5 Blackmores Limited
11.5.1 Overview
11.5.2 Financial Performance
11.5.3 Product Outlook
11.5.4 Key Developments

11.6 Nbty Inc.
11.6.1 Overview
11.6.2 Financial Performance
11.6.3 Product Outlook
11.6.4 Key Developments

11.7 Nutraceutical International Corporation
11.7.1 Overview
11.7.2 Financial Performance
11.7.3 Product Outlook
11.7.4 Key Developments

11.8 Bio-Botanica Inc.
11.8.1 Overview
11.8.2 Financial Performance
11.8.3 Product Outlook
11.8.4 Key Developments

11.9 Arizona Natural Products
11.9.1 Overview
11.9.2 Financial Performance
11.9.3 Product Outlook
11.9.4 Key Developments

11.10 Naturalife Asia Co. Ltd.
11.10.1 Overview
11.10.2 Financial Performance
11.10.3 Product Outlook
11.10.4 Key Developments

12 Appendix
12.1 Related Reports